checkAd

     135  0 Kommentare electroCore, Inc. Announces Johns Hopkins University School of Medicine Study of Non-Invasive Vagus Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients with Gastroparesis and Related Disorders - Seite 4



    1 Camilleri, M; Parkman HP; Shafi MA; Abell T; Gerson L. Clinical guideline: management of gastroparesis. 2013 Jan; 108 (1): 18-37.
    2 Rey E, Choung RS, Schleck CD, Zinsmeister AR, Talley NJ, Locke GR III. Prevalence of hidden gastroparesis in the community: the gastroparesis“iceberg”. J Neurogastroenterol Motil. 2012;18:34–42.
    3 Lacy BE, Crowell MD, Mathis C, Bauer D, Heinberg LJ. Gastroparesis: quality of life and health care utilization. J Clin Gastroenterol. 2018; 52: 20–24.
    4 Harer, K; Pasricha PJ. Chronic Unexplained Nausea and Vomiting or Gastric Neuromuscular Dysfunction (GND) An Update on Nomenclature, Pathophysiology and Treatment and Relationship to Gastroparesis. 2016 Dec; 14 (4): 410-419.

    CONTACT: Investors:
    Rich Cockrell
    CG Capital
    404-736-3838
    ecor@cg.capital
    
    or
    
    Media Contact:
    Summer Diaz
    electroCore
    816-401-6333
    summer.diaz@electrocore.com

    Seite 4 von 4




    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    electroCore, Inc. Announces Johns Hopkins University School of Medicine Study of Non-Invasive Vagus Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients with Gastroparesis and Related Disorders - Seite 4 ROCKAWAY, NJ, April 26, 2021 (GLOBE NEWSWIRE) -  - electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Johns Hopkins University School of Medicine is starting an investigator-initiated trial of …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer